Hormonal Therapy For Prostate Cancer. Luteinizing hormone releasing hormone lhrh agonists block the signal from the pituitary gland that tells the testicles to make testosterone. Huggins and hodges demonstrated the therapeutic effect of gonadal testosterone deprivation in the 1940s and therefore firmly established the concept t.
Hormone therapy is a type of prostate cancer treatment that stops your body from making these hormones or letting them reach cancer cells. Most prostate cancer cells rely on testosterone to help them grow. The cells then die or grow more slowly.
Leuprolide lupron and goserelin zoladex are lhrh agonists.
The cells then die or grow more slowly. Hormone therapy used alone is the standard treatment for men who have a prostate cancer recurrence as documented by ct mri or bone scan after treatment with radiation therapy or prostatectomy. Leuprolide lupron and goserelin zoladex are lhrh agonists. Hormone therapy is a type of prostate cancer treatment that stops your body from making these hormones or letting them reach cancer cells.
